Pfizer Withdraws Oxbryta from Market Due to Safety Concerns

By Richard Waithe, PharmD
Pfizer Withdraws Oxbryta from Market Due to Safety Concerns
Drug Discontinuations & WithdrawalsDrug Safety & RecallsFDA Approvals

Related Articles

FDA Approves First True Generic Flovent HFA for Asthma Treatment
Drug Pricing and Access

FDA Approves First True Generic Flovent HFA for Asthma Treatment

CVS Health to Cover Over-the-Counter Birth Control Pill Opill at No Cost
Drug Pricing and Access

CVS Health to Cover Over-the-Counter Birth Control Pill Opill at No Cost